Capuzzi, David M <br/><br/>
Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia.  [electronic resource] 

 -  Preventive cardiology  2004 
 - 176-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-037X 
<br/><br/><label>Standard No.: </label>10.1111/j.1520-037x.2004.3217.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Apolipoproteins--blood<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Delayed-Action Preparations<br/>Drug Therapy, Combination<br/>Female<br/>Fluorobenzenes--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hyperlipidemias--blood<br/>Male<br/>Middle Aged<br/>Niacin--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Rosuvastatin Calcium<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Triglycerides--blood<br/>United States